The UK Health Security Agency (UKHSA) has issued an urgent appeal to families, urging them to verify eligibility for a crucial NHS vaccination programme targeting meningococcal B (MenB). The agency took to social media to encourage parents to "tag" anyone in Year 13 or preparing for university this autumn, warning that thousands of eligible young people risk missing out on the life-saving jab.
In a message shared with its 190,000 followers, the UKHSA stated: "Know someone with a child in Year 13? Or heading off to uni later this year? Tag them!" The agency noted that just two doses "helps protect against serious illnesses like meningitis."
Who Qualifies for the Free Vaccine?
According to official NHS guidance, the free vaccine is available to "everyone who completes Year 13 in the summer of 2026, born between September 1 2007 and August 31 2008, regardless of whether they go on to further study." Also eligible are "people under 25 who are starting university or moving into certain residential further education accommodation for the first time this autumn," including international students who may not arrive in the UK until September.
Officials emphasised that the offer will not extend to everyone on campus. Postgraduates and students beyond their first year are not covered by the scheme.
Why the Rush? Recent Outbreaks Prompt Acceleration
The one-off programme has been accelerated following a series of concerning outbreaks this year, most notably at the University of Kent in March, where two students died. Meningitis charities say the outbreak claimed the life of 18-year-old Juliette Kenny, whose bereaved family have since fought for broader access to the vaccination. Additional clusters have been reported in Weymouth and Reading.
Health Secretary James Murray stated that the Kent tragedy and following clusters suggested a "possible change to the way MenB affects people," noting that ministers were "acting now to help protect young people at highest immediate risk" while a more comprehensive review takes place.
Dr Shamez Ladhani, a consultant epidemiologist at UKHSA, stated that outbreaks of the illness were uncommon but could be catastrophic, and that two doses were "essential" to provide families with peace of mind as their children depart for halls.
The Dangers of Meningococcal Infection
The illness strikes rapidly and can prove fatal. Meningitis charities caution that meningococcal infection can cause meningitis and septicaemia, is "fatal in around 10% of cases," and can leave those who survive with life-altering injuries including amputations, hearing loss and brain damage.
Freshers face particular vulnerability. Health officials estimate that first-year university students encounter a risk of the illness approximately "seven times greater than their peers who do not go on to higher education," primarily due to the close proximity in halls of residence, at social gatherings and during evenings out.
UKHSA data reveals there were 313 confirmed cases of MenB in England in 2024 to 2025 alone, representing approximately 83% of all invasive meningococcal disease documented.
Doctors state the bacteria can spread between students through routine contact, including "kissing, sharing drinks or vapes, or simply living in close quarters for long periods."
How to Get the Vaccine
Vaccination will be administered through the NHS from late July, with the initial dose available from July 20 and the second in August, a minimum of 28 days later. Year 13 pupils will be contacted directly by the NHS via text, email, letter or the NHS App and invited to book at a local pharmacy. University and college freshers will instead be able to walk in to a participating pharmacy once term begins.
Families are being urged not to wait. While the programme officially continues until the end of the year for first doses, officials caution that cases of the illness typically spike in October and November - precisely when students are settling into halls - making early protection essential.
Common side effects are reported to be mild, and may include a sore arm, a slight fever, headache or nausea, comparable to those encountered with other routine vaccinations. Anyone uncertain about their eligibility is advised to visit the NHS website or get in touch with their GP surgery.
